FDA Inspection
Hybio Pharmaceutical Co. Ltd (Site 1)Hybio Pharmaceutical Co. Ltd (Site 1) – FDA Inspection, Mar 30, 2018
Record Details
This FDA Inspection record concerns Hybio Pharmaceutical Co. Ltd (Site 1), with an inspection on March 30, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 4115f004-9c77-4ede-a375-9407d5e12544
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1051143
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Hybio Pharmaceutical Co. Ltd (Site 1)
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 26, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hybio Pharmaceutical Co. Ltd (Site 1)
- FDA Inspection 936556 - 2015-06-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.